VIDUNDERLIG PHARMACEUTICALS AS
VIDUNDERLIG PHARMACEUTICALS AS is registered as a limited company in Oslo, Oslo with organisation number 929760352. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2022. Registered share capital is NOK 30,000, divided into 1000 shares. The company's stated purpose is: “Utvikling av antistoff-legemiddel konjugat (ADC)- medisin mot HER2(reseptor tyrosine-protein kinase erbB-2), receptor tyrosine-protein kinase erbB-3(HER3) og Tumor-associated calcium signal transducer 2(TROP-2/TACSTD2) positiv brystkreft samt ADC-medisin mot myelomatose og mantle cell lymphom.”. The most recent filed accounts, for the 2024 financial year, show NOK 0 in revenue and NOK 0 in operating profit.
Key figures · 2024
Financial health · 2025
Solidity capped at Weak because equity is below NOK 100,000.
Who owns VIDUNDERLIG PHARMACEUTICALS AS?
VIDUNDERLIG PHARMACEUTICALS AS has 1 registered shareholder:
All shareholders and roles →Frequently asked questions about VIDUNDERLIG PHARMACEUTICALS AS
Who owns VIDUNDERLIG PHARMACEUTICALS AS?
Muisha Rodrig Shekobe Balingene is the largest registered owner, with 100.0%.
What is the revenue of VIDUNDERLIG PHARMACEUTICALS AS?
VIDUNDERLIG PHARMACEUTICALS AS had revenue of NOK 0 in 2024.
Who is the general manager of VIDUNDERLIG PHARMACEUTICALS AS?
Muisha Rodrig Shekobe Balingene is registered as general manager of VIDUNDERLIG PHARMACEUTICALS AS.
Where is VIDUNDERLIG PHARMACEUTICALS AS based?
VIDUNDERLIG PHARMACEUTICALS AS has its business address in Oslo.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.